No More DialysisReported October, 2007
Los Angeles -- Seventy-thousand Americans are waiting for a kidney transplant. A third of them are parked on dialysis because their antibody levels are too high for a transplant. But that's no longer a barrier for some people.
"I used to just sit around and throw up," says former dialysis patient Soraya Kohanzadeh.
Dialysis is something Kohanzadeh would rather forget, but if telling her story saves lives, it's worth it. Kohanzadeh -- like many kidney failure patients -- developed high levels of "anti-donor" antibodies through blood transfusions. Her highly sensitized immune system would likely reject any donated kidney.
"Essentially, she would have a very short, sick life on dialysis," says Joan Lando, Kohanzadeh's mother.
But Kohanzadeh is no longer here, thanks to intravenous immunoglobulin therapy or IVIG. Here's how it works: during dialysis, patients are given blood containing a mix of immunoglobulins, which "turn-off" the anti-donor antibodies' attack response without suppressing the patient's immune system.
"A significant other comes forward, donates an organ, and there's an incompatibility there. We can treat the patient and remove those antibodies. Then the transplant can be done," Stanley Jordan, M.D., director of nephrology at Cedars-Sinai Medical Center in Los Angeles.
More than a year after surgery, Lando's kidney keeps her daughter alive.
"It was sort of shocking to think I wasn't going to have to be sick forever," Kohanzadeh says.
Through their website, this mother-daughter team works to spread the word of a little known therapy that could save thousands in need of a kidney. IVIG is covered by Medicare and can be used in both living and cadaver-donor transplants. Nearly 30 percent of patients on the kidney transplant list might benefit from this therapy. To learn more go to
http://www.sevenluckystars.com.
http://www.ivanhoe.com/science/story/2007/10/341a.html